Literature DB >> 31116848

The role of sham continuous positive airway pressure as a placebo in controlled trials: Best Apnea Interventions for Research Trial.

Michelle L Reid1, Kevin J Gleason1,2, Jessie P Bakker1,3, Rui Wang1,3,4,5, Murray A Mittleman6,7, Susan Redline1,3,7.   

Abstract

STUDY
OBJECTIVES: The main objective of this study was to evaluate the role of sham continuous positive airway pressure (CPAP) compared to conservative medical therapy (CMT) as a control arm in the Best Apnea Interventions for Research (BestAIR) study by assessing differences in subjectively and objectively measured outcomes, adverse events, adherence, and retention rates.
METHODS: BestAIR is a clinical trial aimed to identify important design features for future randomized controlled trials of CPAP. Participants with obstructive sleep apnea were randomized to one of four groups; two control arms (CMT, sham-CPAP) and two active CPAP arms (with and without behavioral interventions). Blood pressure and health-related quality of life outcomes were assessed at baseline, 6 and 12 months. Study outcomes, retention, and adverse event rates were compared between the two control arms. Sham-CPAP adherence and self-efficacy were also compared to active-CPAP adherence (without behavioral intervention).
RESULTS: Our sample included 86 individuals in the control arms and 42 participants in the active-CPAP arm. There were no differences in longitudinal profiles in blood pressure, health-related quality of life outcomes, dropout rates, or adverse events in sham-CPAP group compared to CMT-only group (all ps > 0.05); standardized differences were generally small and with inconsistent directionality across measurements. When compared to active-CPAP, sham-CPAP was associated with 93 fewer minutes/night of usage over 12 months (p = 0.007) and lower outcome expectations (p < 0.05).
CONCLUSION: We observed no evidence of differences in objectively or subjectively measured outcomes with the use of sham-CPAP compared to CMT group. The lower adherence on sham-CPAP and poorer self-efficacy compared to active-CPAP may suggest differences in perceived benefit. REGISTRATION: NCT01261390 Best Apnea Interventions for Research (BestAIR) www.clinicaltrials.gov. © Sleep Research Society 2019. Published by Oxford University Press on behalf of the Sleep Research Society. All rights reserved. For permissions, please e-mail journals.permissions@oup.com.

Entities:  

Keywords:  CPAP; adherence; clinical trial; placebo; sham; sleep apnea

Mesh:

Substances:

Year:  2019        PMID: 31116848      PMCID: PMC7182666          DOI: 10.1093/sleep/zsz099

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  33 in total

1.  Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point.

Authors:  L Hansson; T Hedner; B Dahlöf
Journal:  Blood Press       Date:  1992-08       Impact factor: 2.835

2.  Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome.

Authors:  Liam S Doherty; John L Kiely; Valerie Swan; Walter T McNicholas
Journal:  Chest       Date:  2005-06       Impact factor: 9.410

3.  Nasal Dilator Strip is an Effective Placebo Intervention for Severe Obstructive Sleep Apnea.

Authors:  Fabiana Yagihara; Geraldo Lorenzi-Filho; Rogerio Santos-Silva
Journal:  J Clin Sleep Med       Date:  2017-02-15       Impact factor: 4.062

Review 4.  Reducing cardiovascular risk through treatment of obstructive sleep apnea: 2 methodological approaches.

Authors:  Henry Klar Yaggi; Murray A Mittleman; Dawn M Bravata; John Concato; James Ware; Catherine M Stoney; Susan Redline
Journal:  Am Heart J       Date:  2015-09-11       Impact factor: 4.749

5.  Effects of continuous positive airway pressure on coagulability in obstructive sleep apnoea: a randomised, placebo-controlled crossover study.

Authors:  Craig L Phillips; Bradley J McEwen; Marie-Christine Morel-Kopp; Brendon J Yee; David R Sullivan; Christopher M Ward; Geoffrey H Tofler; Ronald R Grunstein
Journal:  Thorax       Date:  2012-02-14       Impact factor: 9.139

6.  Effect of Continuous Positive Airway Pressure Treatment on Health-Related Quality of Life and Sleepiness in High Cardiovascular Risk Individuals With Sleep Apnea: Best Apnea Interventions for Research (BestAIR) Trial.

Authors:  Ying Y Zhao; Rui Wang; Kevin J Gleason; Eldrin F Lewis; Stuart F Quan; Claudia M Toth; Michael Morrical; Michael Rueschman; Jia Weng; James H Ware; Murray A Mittleman; Susan Redline
Journal:  Sleep       Date:  2017-04-01       Impact factor: 5.849

7.  Challenges in recruitment to a randomized controlled study of cardiovascular disease reduction in sleep apnea: an analysis of alternative strategies.

Authors:  Kevin Gleason; Donghoon Shin; Michael Rueschman; Tanya Weinstock; Rui Wang; James H Ware; Murray A Mittleman; Susan Redline
Journal:  Sleep       Date:  2014-12-01       Impact factor: 5.849

8.  Reliability and validity of the Women's Health Initiative Insomnia Rating Scale.

Authors:  Douglas W Levine; Daniel F Kripke; Robert M Kaplan; Megan A Lewis; Michelle J Naughton; Deborah J Bowen; Sally A Shumaker
Journal:  Psychol Assess       Date:  2003-06

9.  Adherence, reports of benefits, and depression among patients treated with continuous positive airway pressure.

Authors:  Rachel D Wells; Kenneth E Freedland; Robert M Carney; Stephen P Duntley; Edward J Stepanski
Journal:  Psychosom Med       Date:  2007-06-07       Impact factor: 4.312

Review 10.  Adherence to continuous positive airway pressure therapy: the challenge to effective treatment.

Authors:  Terri E Weaver; Ronald R Grunstein
Journal:  Proc Am Thorac Soc       Date:  2008-02-15
View more
  3 in total

1.  A Randomized, Controlled, Pilot Study of CPAP for Patients with Chronic Cough and Obstructive Sleep Apnea.

Authors:  Krishna M Sundar; Alika M Willis; Sarah Smith; Nan Hu; Jay P Kitt; Surinder S Birring
Journal:  Lung       Date:  2020-04-30       Impact factor: 2.584

2.  Effect of continuous positive airway pressure treatment on ambulatory blood pressures in high-risk sleep apnea patients: a randomized controlled trial.

Authors:  Ying Y Zhao; Rui Wang; Kevin J Gleason; Eldrin F Lewis; Stuart F Quan; Claudia M Toth; Yue Song; Michael Morrical; Michael Rueschman; Murray A Mittleman; Susan Redline
Journal:  J Clin Sleep Med       Date:  2022-08-01       Impact factor: 4.324

3.  Sleep Apnea and Fetal Growth Restriction (SAFER) study: protocol for a pragmatic randomised clinical trial of positive airway pressure as an antenatal therapy for fetal growth restriction in maternal obstructive sleep apnoea.

Authors:  Alex Hincker; Jacob Nadler; Suzanne Karan; Ebony Carter; Shay Porat; Barbara Warner; Yo-El S Ju; Arbi Ben Abdallah; Elizabeth Wilson; Ellen M Lockhart; Yehuda Ginosar
Journal:  BMJ Open       Date:  2021-06-29       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.